VRTX
Vertex Pharmaceuticals Inc
Price:  
550.87 
USD
Volume:  
1,213,008.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex Intrinsic Value

4.00 %
Upside

What is the intrinsic value of Vertex?

As of 2026-11-10, the Intrinsic Value of Vertex Pharmaceuticals Inc (VRTX) is 572.83 USD. This Vertex valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 550.87 USD, the upside of Vertex Pharmaceuticals Inc is 4.00%.

The range of the Intrinsic Value is 346.24 - 1,975.44 USD

Is Vertex undervalued or overvalued?

Based on its market price of 550.87 USD and our intrinsic valuation, Vertex Pharmaceuticals Inc (VRTX) is undervalued by 4.00%.

550.87 USD
Stock Price
572.83 USD
Intrinsic Value
Intrinsic Value Details

Vertex Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 346.24 - 1,975.44 572.83 4.0%
DCF (Growth 10y) 399.20 - 2,122.49 640.36 16.2%
DCF (EBITDA 5y) 384.47 - 442.16 410.36 -25.5%
DCF (EBITDA 10y) 432.72 - 534.18 478.44 -13.1%
Fair Value 392.16 - 392.16 392.16 -28.81%
P/E 458.99 - 580.40 492.15 -10.7%
EV/EBITDA 346.16 - 433.98 381.01 -30.8%
EPV 181.41 - 247.65 214.53 -61.1%
DDM - Stable 218.80 - 1,739.74 979.27 77.8%
DDM - Multi 319.24 - 1,971.87 549.31 -0.3%

Vertex Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 139,623.52
Beta 0.44
Outstanding shares (mil) 253.46
Enterprise Value (mil) 137,816.81
Market risk premium 4.60%
Cost of Equity 6.92%
Cost of Debt 6.75%
WACC 6.91%